Subgroup results also showed that high risk of lung and nasopharyngeal cancer could be found in both smokers and nonsmokers, but GSTM1-null could lead to increased cancer risks of the stomach, the cervical and the bladder even nonsmoking (Table 4). This evidence concerns the gene GSTM1 and nasopharyngeal carcinoma.